Relevantly, expression of MIR196A1 miRNA has been correlated with expression of the endometrial cancer candidate target gene KLF5 in breast tumors, and has been associated with poor outcome in breast and ovarian cancer patients [43,44]. Here, KLF5 is linked to ovarian carcinoma.